Home
Latest
E-paper
Companies
Industry
Economy
WebinarsNew
Deep DiveNew
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP
At 01:38 pm; the stock was up 13% at Rs 231, the top gainer among the S&P BSE Smallcap index.
Pre-qualification is a process under which drug companies have to fulfil certain WHO-stipulated conditions
